journal article·2019-04

The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment

Na Fan, Rongzheng Liu, Pingping Ma, Xin Wang, Chang Li, Jing Li

Publisher page

Abstract

In the current stage, the On-Off mechanism of chiral mesoporous silica nanoparticles (CMSN) for delivering achiral drug in chiral environment has rarely been reported. Herein, On-Off chiral mesoporous silica nanoparticles (On-Off-D-CMSN and On-Off-L-CMSN) were successfully synthesized and its particular contribution in delivering achiral drug indometacin (IMC) in chiral environment was mainly studied. The as-synthesized On-Off-D-CMSN and On-Off-L-CMSN were verified by fourier transform infrared spectrometer and circular dichroism. The transmission electron microscope test and nitrogen adsorption/desorption analysis showed that On-Off-D-CMSN and On-Off-L-CMSN were regular spheres with concealed pore channels. The zeta potential analysis demonstrated that the grafting functional groups distributed on the inner and outer surfaces of On-Off-D-CMSN and On-Off-L-CMSN. Through dissolution experiment, the drug release of IMC loaded On-Off-D-CMSN (84%) and IMC loaded On-Off-L-CMSN (70%) were about 2.4 and 2.0 times higher than pure IMC (35%) in pH 6.8 phosphate buffer solution (PBS), respectively. IMC loaded On-Off-D-CMSN and IMC loaded On-Off-L-CMSN exerted different chiral recognition functions with On-Off mechanism in in-vitro chiral environment (pH 6.8 PBS-L and pH 6.8 PBS-D). The results of anti-inflammation pharmacodynamics further demonstrated that On-Off-D-CMSN and On-Off-L-CMSN can trigger chiral biological environment to achieve on or off chiral recognition functions. The unique advantages of On-Off chiral mesoporous silica nanoparticles in triggering chiral biological environment can provide valuable instruction for designing drug delivery system.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesoporous Materials and Catalysis · Supramolecular Self-Assembly in Materials · Drug Transport and Resistance Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. Three-dimensional reconstruction of biological macromolecular complexes from in-lens scanning electron micrographs10.1111/j.1365-2818.2009.03168.x ↗
2. Understanding the growth of Eu2O3 nanocrystal films made via electrophoretic deposition10.1088/0957-4484/21/14/145704 ↗
3. Reconfigurable self-assembly through chiral control of interfacial tension10.1038/nature10769 ↗
4. Controlling supramolecular chirality of two-component hydrogels by J- and H-aggregation of building blocks10.1021/jacs.8b03309 ↗
5. Chirality of metal nanoparticles in chiral mesoporous silica10.1002/adfm.201200588 ↗
6. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function10.1016/j.msec.2018.04.071 ↗
7. Mesoporous silica nanoparticles in biomedical applications10.1039/c1cs15246g ↗
8. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging10.1016/j.colsurfb.2013.04.009 ↗
9. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug10.1016/j.ijpharm.2015.07.014 ↗
10. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals10.1002/smll.201000538 ↗
11. On the controllable soft-templating approach to mesoporous silicates
12. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study10.1016/j.ejpb.2011.12.002 ↗
13. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers10.1016/j.ejps.2015.02.008 ↗
14. Mesoporous silica formulation strategies for drug dissolution enhancement: a review10.1517/17425247.2016.1100165 ↗
15. Autofluorescent and pH-responsive mesoporous silica for cancer-targeted and controlled drug release10.1016/j.micromeso.2013.11.006 ↗
16. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release10.2147/IJN.S146955 ↗
17. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers10.1002/adma.201001417 ↗
18. Light-operated mechanized nanoparticles10.1021/ja807798g ↗
19. Ultrasound-triggered smart drug release from a poly(dimethyl siloxane)–mesoporous silica composite10.1002/adma.200600387 ↗
20. Chiral mesoporous silica: chiral construction and imprinting via cooperative self-assembly of amphiphiles and silica precursors10.1039/C0CS00002G ↗
21. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells10.1016/j.actbio.2015.05.010 ↗
22. Understanding the mechanism of chirality transfer in the formation of a chiral MCM-41 mesoporous silica10.1021/jp1059825 ↗
23. Impact of cross-linking and drying method on drug delivery performance of casein-pectin microparticles10.1208/s12249-013-0012-8 ↗
24. Effect of complexes and microemulsions on the permeability of drugs: determination using a new biomimetic artificial membrane10.1208/s12249-018-1096-y ↗
25. The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity10.1016/j.ijpharm.2018.10.055 ↗
26. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica10.2147/IJN.S52605 ↗
27. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity10.1016/j.colsurfb.2016.02.009 ↗
28. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy10.1016/j.colsurfb.2017.11.006 ↗
29. Supramolecular chirality in organo-, hydro-, and metallogels derived from bis-amides of L-(+)-tartaric acid: formation of highly aligned 1D silica fibers and evidence of 5-c net SnS topology in a metallogel network10.1002/chem.201200871 ↗
30. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization10.1016/j.colsurfb.2018.02.019 ↗
31. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers10.1016/j.addr.2008.03.012 ↗
32. Multimodal nanoporous silica nanoparticles functionalized with aminopropyl groups for improving loading and controlled release of doxorubicin hydrochloride10.1016/j.msec.2017.04.060 ↗
33. Clozapine-carboxylic acid plasticized co-amorphous dispersions: preparation, characterization and solution stability evaluation10.1515/acph-2015-0014 ↗
34. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan10.1016/j.jconrel.2010.04.029 ↗
35. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: superiority of amino modification10.1016/j.msec.2015.10.072 ↗
36. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug10.1016/j.jcis.2011.07.022 ↗
37. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions10.1016/j.carbpol.2017.12.004 ↗